The PhRMA Foundation and the Journal of Managed Care & Specialty Pharmacy issued a competitive call for papers examining crucial challenges in the implementation of the Inflation Reduction Act by the Centers for Medicare & Medicaid Services. Three winning submissions will receive a $25,000 Challenge Award and be published in JMCP.
After watching his father battle cancer and experience severe pain every day with no relief from medicines, PhRMA Foundation awardee Ding Quan “Quinton” is now using real-world data to assess the value of acupuncture for treating cancer-related pain.
After witnessing her brother's battle with blood cancer, PhRMA Foundation awardee Dr. Lydie Debaize, a postdoc at Dana Farber Cancer Institute, has dedicated her scientific career to developing novel therapeutic strategies for blood cancers.
Dr. Fatima Rivas, an assistant professor at Louisiana State University, studies chemical compounds found in nature and how they can be altered in the laboratory to treat diseases. Learn how she become interested in studying natural compounds in this blog.
A fellowship is a great way to learn what it's like working at a biopharmaceutical company. The PhRMA Foundation will host fellows from UCB's PharmD Fellowship Program to talk about their experiences and answer questions.
Driving Progress in U.S. Value Assessment
Value assessment is a field of research that seeks to evaluate the relative benefits and costs of health care interventions — such as pharmaceuticals, medical devices, or medical procedures — to ensure health care decisions are guided by the best possible evidence. In a new white paper, the PhRMA Foundation reviews the U.S. value assessment landscape, identifies key challenges, and highlights how Foundation-funded researchers are working toward solutions that will advance the field. Read the paper.
Centers of Excellence in Value Assessment
The Awards
With a wide range of predoctoral and postdoctoral fellowships and research grants, the Foundation offers a myriad of opportunities to advance your career.
Featured Scientist
Dr. Yongbin Liu, a postdoctoral fellow at Houston Methodist Research Institute, is working to develop safer, more potent drugs that can overcome the limitations of current chemotherapy medicines. He received a 2023 PhRMA Foundation award for his research on novel nanomedicine drugs that can conquer drug resistance and have a lower toxicity in order to better treat refractory cancers. Watch this video to learn about Liu and his research.
Announcements
Webinar: How to Write a Standout Letter of Intent and Application
What are reviewers looking for when they assess letters of intent and applications for research funding? In this webinar, a former PhRMA Foundation Scientific Advisory Committee member discusses the do’s and don’ts of writing LOIs and grants.
PhRMA Foundation Welcomes Robert Plenge to the Board of Directors
The PhRMA Foundation today announced the appointment to its Board of Directors of Robert Plenge, MD, PhD, Executive Vice President, Head of Research at Bristol Myers Squibb (BMS).
Learn More About PhRMA Foundation Funding Opportunities
The PhRMA Foundation offers a wide variety of research grants, in categories ranging from predoctoral to postdoctoral and spanning several scientific disciplines. Check our awards page to learn more.
See the list of grant opportunities here.
